Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
University of Washington
University of Washington
City of Hope Medical Center
Mayo Clinic
University of Washington
Fred Hutchinson Cancer Center
Mayo Clinic
City of Hope Medical Center
City of Hope Medical Center
Alliance for Clinical Trials in Oncology
Mayo Clinic
City of Hope Medical Center
Roswell Park Cancer Institute
City of Hope Medical Center
University of Washington
St. Joseph's Hospital and Medical Center, Phoenix
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Case Comprehensive Cancer Center